: A birth defect resulting from exposure to the study product.
: Required to prevent one of the outcomes listed above. Required Reporting Information SAE Reporting and the IRB: Adverse Events in Drug Studies
This information pertains to the reporting of in clinical trials, a critical regulatory requirement for maintaining patient safety and data integrity. Core Reporting Timelines Sae__.mp4
: The participant was at immediate risk of death at the time of the event.
: Sponsors have specific windows for notifying regulatory bodies like the FDA, often ranging from 7 to 15 calendar days depending on the event's severity and whether it was unexpected. : A birth defect resulting from exposure to
: Any new or updated information regarding an existing SAE must also be provided promptly, typically within 24 hours of the investigator obtaining the new details. Criteria for an SAE
: Investigators must generally report an SAE to the sponsor within 24 hours of becoming aware of the event. Core Reporting Timelines : The participant was at
An event is classified as "serious" if it meets one or more of the following criteria: : Regardless of the perceived cause.